Citation Impact
Citing Papers
Interleukin-6 Overexpression Induces Pulmonary Hypertension
2008
Where Does Serum Amylase Come From and Where Does It Go?
1990
Synovial tissues concentrate secreted APRIL
2009
Developmental changes in heparan sulfate expression: in situ detection with mAbs.
1992
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
2006 StandoutNobel
Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings
1999
NF-κB signaling in inflammation
2017 Standout
Sjögren's syndrome
2005 Standout
Role of bone marrow cells in autoantibody production and lymphoproliferation in the novel mutant strain of mice, CBA/KIJms‐lprcg/lprcg
1991
Accelerated Systemic Autoimmunity in the Absence of Somatic Hypermutation in 564Igi: A Mouse Model of Systemic Lupus with Knocked-In Heavy and Light Chain Genes
2017 StandoutNobel
The role of BAFF in the progression of rheumatoid arthritis
2015
Treatment of Pulmonary Arterial Hypertension
2004 Standout
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Genetic Analysis of Innate Immunity
2006 StandoutNobel
Differences in synovial tissue infiltrates between anti–cyclic citrullinated peptide–positive rheumatoid arthritis and anti–cyclic citrullinated peptide–negative rheumatoid arthritis
2007
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Updated Clinical Classification of Pulmonary Hypertension
2009 Standout
Cellular and molecular pathobiology of pulmonary arterial hypertension
2004 Standout
Cognitive impairment in multiple sclerosis
2008 Standout
An Evolutionary and Functional Approach to the TNF Receptor/Ligand Family
1994 StandoutNobel
A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-1 expression in ischemia/reperfusion
2002
Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
1992 StandoutNature
A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus
2001
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Scleroderma
2009 Standout
Biomarkers in systemic lupus erythematosus: II. Markers of disease activity
2004
IL-6 as a keystone cytokine in health and disease
2015 Standout
Fcγ receptors as regulators of immune responses
2007 Standout
Intracellular Toll-like Receptors
2010 StandoutNobel
Neuropsychological Impairment in Systemic Lupus Erythematosus: A Comparison with Multiple Sclerosis
2008
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis
2005
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
2007 Standout
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Toll-Like Receptors and Activation of Autoreactive B Cells
2002
Complement Deficiency and Autoimmunitya
1997
Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression
1998
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Innate immune recognition of viral infection
2006 Standout
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study
2013 Standout
Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
2008 StandoutNobel
Acute Pancreatitis
1994 Standout
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
The Fas Death Factor
1995 StandoutScience
Rheumatoid arthritis
2010 Standout
Update on vascular disease in systemic lupus erythematosus
2003
IgG4-related disease
2014 Standout
Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA
2005 StandoutNobel
The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9
2006 StandoutNobel
Recognition of Hyaluronan Released in Sterile Injury Involves a Unique Receptor Complex Dependent on Toll-like Receptor 4, CD44, and MD-2
2007 StandoutNobel
Musculoskeletal involvement in scleroderma
2003
Toll‐like receptors, endogenous ligands, and systemic autoimmune disease
2005
Points of control in inflammation
2002 StandoutNature
Astrocyte–endothelial interactions at the blood–brain barrier
2005 Standout
Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates
2009
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
Neutrophil recruitment and function in health and inflammation
2013 Standout
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
Inflammation in pulmonary arterial hypertension
2003
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis
2003
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Plasma Monocyte Chemoattractant Protein-1 and Pulmonary Vascular Resistance in Chronic Thromboembolic Pulmonary Hypertension
2001
An improved ELISA for anti-native DNA by elimination of interference by anti-histone antibodies
1983
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
Thymus and autoimmunity: capacity of the normal thymus to produce pathogenic self-reactive T cells and conditions required for their induction of autoimmune disease.
1990 StandoutNobel
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Nitric oxide and the immune response
2001 Standout
Immune Complexes Present in the Sera of Autoimmune Mice Activate Rheumatoid Factor B Cells
2000
Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases.
2003
Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis
2004
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
The angiopietin-1–Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice
2009
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
Imaging the glycome
2008 StandoutNobel
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes
2004
Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment.
2002
Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis
2010
FcR-Bearing Myeloid Cells Are Responsible for Triggering Murine Lupus Nephritis
2006
WHICH PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODY SHOULD BE TREATED AND HOW?
1993
A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse.
1990
Works of S Aotsuka being referenced
Analysis of negatively charged dye-binding antibodies reactive with double-stranded DNA and heparan sulfate in serum from patients with rheumatic diseases.
1988
C1q-Binding Immunoglobulin G in MRL/I Mice Consists of Immune Complexes Containing Antibodies to DNA
1995
Expression of BAFF and BAFF‐R in the synovial tissue of patients with rheumatoid arthritis
2007
Detection of autoantibody against carbonic anhydrase II in various liver diseases by enzyme-linked immunosorbent assay using appropriate conditions
2004
Rheumatoid arthritis fibroblast‐like synoviocytes express BCMA and are stimulated by APRIL
2007
Clinical and laboratory features of lupus patients with complicating pulmonary disease
1999
Selective removal of anti-DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus.
1991
Measurement of anti-double-stranded DNA antibodies in major immunoglobulin classes
1979
Production of intracellular and extracellular interleukin-1 alpha and interleukin-1 beta by peripheral blood monocytes from patients with connective tissue diseases.
1991
Anticalmodulin autoantibody in liver diseases: A new antibody against a cytoskeleton-related protein
1987
Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases
2001
A simple and rapid microenzyme-linked immunosorbent assay for antibodies to poly(ADP-ribose) in systemic lupus erythematosus
1982
Amylase in the thyroid gland
1982
Clinical significance of the serum lipoprotein(a) level in patients with systemic lupus erythematosus: its elevation during disease flare.
1997
Up-regulation of intercellular adhesion molecule-1 (ICAM-1), endothelial leucocyte adhesion molecule-1 (ELAM-1) and class II MHC molecules on pulmonary artery endothelial cells by antibodies against U1-ribonucleoprotein
1999
Clinical significance of serum thrombomodulin levels in patients with systemic rheumatic diseases.
1997
Immunological analysis of pulmonary hypertension in connective tissue diseases.
1999
[Preliminary criteria for the diagnosis of pulmonary hypertension in mixed connective tissue disease].
1991
Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD)
1994
A retrospective study of the fluctuation in serum levels of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis.
2005
Comparable histological appearance of synovitis in seropositive and seronegative rheumatoid arthritis.
1997
Heterogeneity of Antilymphocyte Antibody in Sle and Its Correlation with Disease Activity
1983
Characterization of C1q-binding IgG complexes in systemic lupus erythematosus
1984
Emergence of erosive polyarthritis coincident with Mycobacterium kansassi pulmonary infection in a patient with systemic sclerosis-rheumatoid arthritis overlap syndrome.
2000